Literature DB >> 34912036

Off-the-shelf, gene-edited CAR-T cells forge ahead, despite safety scare.

Cormac Sheridan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34912036     DOI： 10.1038/d41587-021-00027-1

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

Review 1.  Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing.

Authors:  Dimitrios L Wagner; Ulrike Koehl; Markus Chmielewski; Christoph Scheid; Renata Stripecke
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

2.  An Alternative Source for Allogeneic CAR T Cells With a High Safety Profile.

Authors:  Xiaolong Wu; Ingo G H Schmidt-Wolf
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.